StepanSCL
SCL logo
Fair Value
US$75
Share price18 Jun
US$56.8524.2% undervalued intrinsic discount
Loading
1Y-1.25%
7D4.03%

Pasadena Site And Tech Integration Will Unlock Future Opportunities

Analyst Consensus Target compiles analysts opinions to create narratives on stocks using the Analysts Consensus Price Target, forecasted revenue and earnings figures, as well as the transcripts of earnings calls.

Published
24 Sep 24
Updated
18 Jun 26
Views
191
Not Invested

Shared on 30 Apr 25

Fair value Increased 2.58%
2 viewsusers have viewed this narrative update

Shared on 23 Apr 25

Fair value Decreased 4.69%
0 viewsusers have viewed this narrative update

Shared on 17 Apr 25

0 viewsusers have viewed this narrative update

Shared on 09 Apr 25

0 viewsusers have viewed this narrative update

Shared on 02 Apr 25

Fair value Increased 1.58%
1 viewusers have viewed this narrative update

Shared on 26 Mar 25

0 viewsusers have viewed this narrative update

Shared on 19 Mar 25

1 viewusers have viewed this narrative update

Shared on 11 Mar 25

Fair value Decreased 2.62%
0 viewsusers have viewed this narrative update

Fair Value vs Share Price

US$75
vs US$56.8524.2% undervalued intrinsic discount
PastFuture03b2015201820212024202620272029Revenue US$2.8bEarnings US$137.8m
5.7%
Revenue growth
5%
Profit margin

Recent News & Updates

No updates

Recent updates

No updates

Stay ahead on Stepan

  • Fair value estimate changes
  • Narrative and analyst updates
  • Key company announcements

Company analysis

Undervalued with moderate growth potential.

Market capUS$1.3b
PB1.1x
Estimated Growth4.7%
Dividend Yield2.8%
Full analysis

CEO & management

Luis Rojo
CEO
2.5yrs
CEO Tenure

Produces and sells specialty and intermediate chemicals to other manufacturers for use in various end products in the United States, France, Poland, the United Kingdom, Brazil, Mexico, and internationally.